https://www.selleckchem.com/products/foxy5.html
onths (range 2-84months). Patients with local recurrence had PFS of 5and 8months. Five patients developed distant metastases. Fifteen patients (48%) underwent intracervical curettage 3months after completion of treatment of which 14(93%) had complete pathologic response. Brachytherapy remains the standard of care for patients diagnosed with cervical cancer and indication for primary chemoradiation. In terms of local control, CyberKnife®-based boost concepts provide excellent local control. It can be an alternative for patients who cannot
Like
Comment
Share
